Strand Life Sciences is a genomics-based
research and diagnostics company with a
mission to improve global health by
decoding the genetic information contained
in an individual’s genome.
Strand Life Sciences partnership
programs enable large-scale
genomics research studies
Our powerful genomics solutions accelerate drug discovery research for Pharma and biotech companies. Our unique access to genomics data with clinical and phenotypic data provides insights into complex diseases at the genetic and molecular level to facilitate research in personalized healthcare.
We have revolutionized healthcare by reducing trial-and-error in treatment through the application of diagnostics and genomic testing through our innovative laboratory tests, technology, and platform solutions used by clinicians for their patients, scientific researchers, as well as pharmaceutical and biotech companies.
We provide end-to-end
solution for genomic testing
services in the areas of cancer
and rare diseases.
For close to 2 decades, we have been at the forefront of developing robust and sophisticated bioinformatics solutions based on our proprietary platforms Ramanujan and Avadis, for global pharmaceutical and leading research laboratories. Some of our developments include:
One of the foremost software
products built by Strand with 20,000
citations and used by 2000+
Complete turnkey solution that
with laboratory and informatics infrastructure/ support
to enable patient-centric genomic medicine.
Enables analysis of data
generated from next-generation
sequencing (NGS) experiments.
Providing clinical reports with deep insights and fast turn-around to global hospitals and genetic laboratories for making informed clinical decisions on their patient samples.
You don’t just get reports from Strand. You get a committed partner with the expertise, experience and capability to help you make the right clinical decisions for your patients
The Strand Edge:
Proprietary software and variant curation databases that enable automatic variant prioritization, clinical interpretation and report generation.
Strand NGS – Analysis of data generated from next-generation sequencing (NGS®) experiments.
Data analytics, technology and Artificial Intelligence to see patterns and integrate them into decision models.
Clinical research and development services in the areas of clinical trial management, biomarker discovery, and validation.
Over 2000 customers including the world’s premier research institutes, pharmaceutical and biotechnology companies, device makers, regulatory bodies, hospitals and doctors have used our products and services for making crucial decisions.